10 Results for "

antiglaucoma

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "antiglaucoma" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B0600
CAS No.: 209860-87-7
Synonyms: AFP-168; MK2452
Research Areas:  

Cardiovascular Disease Others

Tafluprost (AFP-168) is an anti-glaucoma prostaglandin (PG) analog. Tafluprost can inhibit the apoptosis of retinal ganglion cells (RGCs) and rat RGCs cells. Tafluprost promotes axon regeneration by regulating Zn 2+-mTORpathway, inhibits intracellular lipid accumulation in human preorbital adipocytes. Tafluprost can be used in the study of optic nerve injury in glaucoma .
loading...
    loading...
Cat. No.: HY-109545
CAS No.: 120373-24-2
Purity:  95.1%
Synonyms: Unoprostone isopropyl ester; UF-021
Target:  

Potassium Channel

Research Areas:  

Others

Isopropyl unoprostone (Unoprostone isopropyl ester), an analogue of a prostaglandin metabolite, is a potent large conductance Ca 2+-activated K + (BK) channels activator. Isopropyl unoprostone has antiglaucoma effects, lowering intraocular pressure (IOP) by increasing aqueous humour outflow. Isopropyl unoprostone can improve retinal sensitivity and the protection of central retinal sensitivity .
loading...
    loading...
Cat. No.: HY-115462
CAS No.: 863704-91-0
Purity:  98.90%
Research Areas:  

Inflammation/Immunology

PGN-9856 is a selective and high affinity (pKi ≥ 8.3) ligand at EP2 receptor. PGN-9856 is a potetn and non-prostanoid EP2 receptor agonist (pEC50 ≥ 8.5). PGN-9856 shows anti-inflammatory and anti-glaucoma activities .
loading...
    loading...
Cat. No.: HY-W031519
CAS No.: 121-30-2
Target:  

Carbonic Anhydrase

Research Areas:  

Cardiovascular Disease

Chloraminophenamide (Compound 14) is a carbonic anhydrase inhibitor, with Kis of 75, 160 and 8400 nM for hCA II, bCA IV and hCA I, respectively. Chloraminophenamide has the potential for antiglaucoma research .
loading...
    loading...
Cat. No.: HY-168802
CAS No.: 261179-75-3
Research Areas:  

Cardiovascular Disease

9-Keto tafluprost is a derivative of Tafluprost (HY-B0600). Tafluprost is an anti-glaucoma prostaglandin (PG) analog .
loading...
    loading...
Cat. No.: HY-118215
CAS No.: 1192760-33-0
Synonyms: AGN212409
Research Areas:  

Others

Aganepag ethanediol (AGN212409) is an EP2 (Prostaglandin Receptor) receptor agonist. Aganepag ethanediol may be used in anti-glaucoma research .
loading...
    loading...
Cat. No.: HY-B0600R
CAS No.: 209860-87-7
Synonyms: AFP-168 (Standard); MK2452 (Standard)
Tafluprost (Standard) is the analytical standard of Tafluprost. This product is intended for research and analytical applications. Tafluprost (AFP-168) is an anti-glaucoma prostaglandin (PG) analog. Tafluprost can inhibit the apoptosis of retinal ganglion cells (RGCs) and rat RGCs cells. Tafluprost promotes axon regeneration by regulating Zn2+-mTORpathway, inhibits intracellular lipid accumulation in human preorbital adipocytes. Tafluprost can be used in the study of optic nerve injury in glaucoma [4] .
loading...
    loading...
Cat. No.: HY-187890
CAS No.: 215863-14-2
Research Areas:  

Neurological Disease

Besvoprost is a prostaglandin receptor activator with antiglaucoma activity. Besvoprost can be used for the research of glaucoma .
loading...
    loading...
Cat. No.: HY-184937
COX-2/CA II-1 is an orally active dual selective inhibitor targeting COX-2 and hCA II. COX-2/CA II-1 inhibits COX-2 with an IC50 value of 0.13 μM (SI = 9.25 vs COX-1) and hCA II with a Ki value of 39.1 nM (SI = 933.8 vs hCA I). COX-2/CA II-1 demonstrates significant analgesic and anti-inflammatory effects in animal models, shows improved gastric safety with reduced ulcerogenic liability, and exhibits intraocular pressure (IOP)-lowering effects in rabbit glaucoma models. COX-2/CA II-1 can be used for anti-inflammatory, analgesic and antiglaucoma research .
loading...
    loading...
Cat. No.: HY-184938
COX-2/CA II-2 is an orally active dual selective inhibitor targeting COX-2 and hCA II. COX-2/CA II-2 inhibits COX-2 with an IC50 value of 0.05 μM (SI = 12.02 vs COX-1) and hCA II with a Ki value of 62.6 nM (SI = 704.2 vs hCA I). COX-2/CA II-2 demonstrates significant analgesic and anti-inflammatory effects with rapid onset and sustained duration in animal models, shows improved gastric safety with reduced ulcerogenic liability, and exhibits a gradual intraocular pressure (IOP)-lowering effect without statistical significance relative to the sham-treated eye in rabbit glaucoma models. COX-2/CA II-2 can be used for anti-inflammatory, analgesic and antiglaucoma research .
loading...
    loading...